White House announces new round of drug-price deals

Photo: President Donald Trump signs an executive order on Delivering Most-Favored-Nation Prescription Drug Pricing to American Patient at a press conference with Health and Human Services Secretary Robert F. Kennedy Jr., Monday, May 12, 2025, in the Roosevelt Room. Photo credit: Official White House photo by Joyce N. Boghosian via Flickr. US government work. Article by Yuki Noguchi. NPR – December 19, 2025.

President Trump said the administration has reached agreements with nine more drugmakers to bring their U.S. drug prices more in line with what other wealthy countries pay. Fourteen companies in total have now reached what the administration calls most-favored-nation pricing deals. The companies that took part in Friday’s announcement were: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi. […]

Click here to view original web page at www.npr.org